Reflections on IL-2: A Catalyst for Transformational Discoveries in Immunology
IL-2’s legacy extends beyond its immediate applications, highlighting the unpredictable nature of scientific discovery a...
Found 513 results
IL-2’s legacy extends beyond its immediate applications, highlighting the unpredictable nature of scientific discovery a...
As midterms approach, Robert F. Kennedy Jr.'s Make America Healthy Again movement faces challenges in visibility and sup...
Argenx's Vyvgart failed in a Phase 3 trial for Sjögren's disease, while Evenamide faces regulatory hurdles after safety...
STAT recently won multiple prestigious awards, highlighting its impactful healthcare reporting, even as political moveme...
Life Biosciences shares significant findings regarding their glaucoma treatment, emphasizing advancements in cellular re...
A recent analysis highlights the link between pharmaceutical payments to doctors and increased inappropriate prescribing...
The American Hospital Association is suing the Trump administration again over a controversial drug rebate pilot, citing...
Steven Quay, once a frontrunner for the top infectious disease role, will now shift to a consulting position, with no in...
Caribou Biosciences is ceasing operations after unsuccessful funding efforts for a pivotal CAR-T lymphoma clinical trial...
Henri B. Kagan and Kenso Soai received the 2026 Nobel Prize in Chemistry for their work on manipulating chiral molecules...
Recent research reveals that emergency room visits among immigrant populations plummeted after heightened ICE enforcemen...
The DOJ's new directive signals an intensified focus on combating fraud in the pharmaceutical industry, expanding its en...
The WHO's recent guidelines tackle the alarming rise in childhood obesity, while Caribou Biosciences ceases operations o...
The newsletter writer takes aim at scientific errors in “The Love Hypothesis” and invites health tech tips and consultin...
Forbion's recent fundraising milestone of $2.6 billion sets a significant benchmark in the biotech investment arena.
Merck's new Keytruda formulation has hit a legal snag in Europe due to a court ruling that halts its production in sever...
PhRMA has filed a lawsuit against the Trump administration's Medicare drug pricing pilot, claiming it exceeds statutory...
Recent research showcases optogenetics as a promising approach for restoring vision in retinitis pigmentosa patients, sp...
A recent SNL sketch skillfully highlights how personalized algorithms can distort our perceptions and connections in rea...
A firsthand account of heat-related incidents at the NYC Marathon highlights the urgent need for better medical planning...